Harvard Radiation Oncology Program
Boston, MA

Disclosures:

Presentations

Sep 28

2534 - High PD-L1 Expression is Associated with Adaptive Replanning in Patients with Locally Advanced (LA) Non-Small Cell Lung Carcinoma (NSCLC) Treated with Chemoradiotherapy (chemoRT)
Hall F
04:45pm - 06:00pm PT